1. Editorial: Thrombosis prophylaxis with new anticoagulants: Routine and specific risk groups

   • Sibylle A. Kozek-Langenecker

   Editorial 01 February 2011 Pages: 53 - 53

2. New anticoagulants: pharmacology and clinical studies

   • Charles Marc Samama

   Themenschwerpunkt 01 February 2011 Pages: 54 - 57

3. Monitoring of direct anticoagulants

   • Susanne Lison
   • Michael Spannagl

   Themenschwerpunkt 01 February 2011 Pages: 58 - 62

4. New anticoagulants: perioperative considerations

   • Sibylle A. Kozek-Langenecker

   Themenschwerpunkt 01 February 2011 Pages: 63 - 67

5. Thrombosis prophylaxis in critically ill patients

   • Dietmar Fries

   Themenschwerpunkt 01 February 2011 Pages: 68 - 72

6. Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children

   • Werner Streif
   • Walter Ageno

   Themenschwerpunkt 01 February 2011 Pages: 73 - 79

7. Actovegin^®: a biological drug for more than 5 decades

   • Florian Buchmayer
   • Johannes Pleiner
   • Harald H. Sitte

   Review 01 February 2011 Pages: 80 - 88

8. Österreichische Patienteninformationsmaterialien zu PSA-Screening entsprechen nicht internationalen evidenzbasierten Standards

   • Michaela Strobelberger
   • Angela Kaminski
   • Gerald Gartlehner

   Originalarbeit 01 February 2011 Pages: 89 - 98

9. Awareness and use of recommendations for withholding and withdrawing therapy in Austrian intensive care units

   • Christian J. Wiedermann
   • Michael Joannidis
   • Andreas Valentin

   Short communication 01 February 2011 Pages: 99 - 102

10. Erratum to: Ginkgo biloba in Alzheimer"s disease: a systematic review

    • Inger M. Janßen
    • Sibylle Sturtz
    • Reinhard Busse

    Erratum 01 February 2011 Pages: 104 - 104